Tag: Pre-IND
Mustang Bio And FDA Complete Pre-IND Meeting For MB-102 (CD123 CAR-T)
Mustang Bio, Inc., a Fortress Biotech Company, headquartered in the greater New York City area, is a clinical‐stage biopharmaceutical company focused on the development and commercialization of novel cancer immunotherapy products designed to leverage the patient’s own immune system...
